{"hands_on_practices": [{"introduction": "The activation of the alternative pathway is critically dependent on the precise molecular environment. The formation of the C3 convertase, C3bBb, is not spontaneous but requires the presence of magnesium ions ($\\mathrm{Mg^{2+}}$) to stabilize the complex. This exercise [@problem_id:2896988] challenges you to quantitatively model this requirement by applying the principles of competitive ligand binding, exploring how the presence of other competing cations like $\\mathrm{Ca^{2+}}$ and $\\mathrm{Ni^{2+}}$ can modulate the pathway's initial activation rate.", "problem": "A research group is quantifying how buffer-imposed divalent cation conditions regulate formation of the Alternative Pathway (AP) C3 convertase via the cation-dependent binding of complement factor B to C3b. They design a kinetic assay in which the measured initial rate of C3a generation is proportional to the concentration of the cation-bound C3bB complex that can be cleaved by factor D. The system has a single divalent cation site on the C3b–factor B assembly. Consistent with established biochemical observations, the following statements hold:\n\n- The site can bind magnesium ions ($\\mathrm{Mg^{2+}}$), nickel ions ($\\mathrm{Ni^{2+}}$), or calcium ions ($\\mathrm{Ca^{2+}}$), but only the $\\mathrm{Mg^{2+}}$-bound complex is fully functional for AP activation, while the $\\mathrm{Ni^{2+}}$-bound complex is partially functional and the $\\mathrm{Ca^{2+}}$-bound complex is functionally inactive for AP activation.\n- The functional efficacy of the $\\mathrm{Ni^{2+}}$-bound state is a fixed fraction $\\alpha$ of the $\\mathrm{Mg^{2+}}$-bound state.\n- Under initial-rate conditions, the initial rate $v$ is proportional to the effective fraction of cation-occupied sites that are catalytically competent (with partial competence appropriately scaled by $\\alpha$).\n- Cation binding to the site follows the law of mass action with dissociation constants $K_{d,\\mathrm{Mg}}$, $K_{d,\\mathrm{Ni}}$, and $K_{d,\\mathrm{Ca}}$.\n\nTwo buffers are compared:\n\n- Buffer A (no ethylene glycol-bis(2-aminoethylether)-$N,N,N',N'$-tetraacetic acid (EGTA), physiological calcium present): measured free ion concentrations are $\\left[\\mathrm{Mg^{2+}}\\right]_{A} = 0.6\\,\\mathrm{mM}$, $\\left[\\mathrm{Ni^{2+}}\\right]_{A} = 0\\,\\mathrm{mM}$, and $\\left[\\mathrm{Ca^{2+}}\\right]_{A} = 1.2\\,\\mathrm{mM}$.\n- Buffer B (EGTA-$\\mathrm{Mg^{2+}}$ buffer suppressing free calcium, with trace nickel added): measured free ion concentrations are $\\left[\\mathrm{Mg^{2+}}\\right]_{B} = 1.0\\,\\mathrm{mM}$, $\\left[\\mathrm{Ni^{2+}}\\right]_{B} = 0.020\\,\\mathrm{mM}$, and $\\left[\\mathrm{Ca^{2+}}\\right]_{B} = 0.001\\,\\mathrm{mM}$.\n\nIndependent equilibrium measurements for the cation site on the C3b–factor B assembly give $K_{d,\\mathrm{Mg}} = 0.20\\,\\mathrm{mM}$, $K_{d,\\mathrm{Ni}} = 0.050\\,\\mathrm{mM}$, and $K_{d,\\mathrm{Ca}} = 2.0\\,\\mathrm{mM}$. The partial efficacy of $\\mathrm{Ni^{2+}}$ is $\\alpha = 0.35$. Assume that factor D is not rate limiting and that $[\\mathrm{C3b}]$ and $[\\mathrm{B}]$ are fixed and sufficiently low that the fraction of cation-bound sites determines the proportional initial rate.\n\nStarting from the law of mass action and site conservation only (do not assume any pre-derived occupancy formula), derive an expression for the initial rate in each buffer in terms of the free ion concentrations and $K_{d}$ values, and compute the fold-change in initial rate $v_{B}/v_{A}$. Express your final answer as a dimensionless number and round to four significant figures.", "solution": "The problem statement has been evaluated and is found to be scientifically grounded, well-posed, and free of contradictions or ambiguities. It presents a standard biochemical problem of competitive ligand binding to a single site, which is a suitable basis for rigorous analysis. All necessary constants and conditions are provided. Therefore, a solution will be provided.\n\nThe core of the problem is to determine the relative catalytic rate under two different conditions, where the rate is governed by the occupancy of a protein binding site by competing divalent cations. The derivation must begin from fundamental principles as specified.\n\nLet $S$ represent the free cation-binding site on the complement C3b-factor B assembly, denoted as $\\mathrm{C3bB}$. Let $[S]_{tot}$ be the total concentration of these sites. The cations $\\mathrm{Mg^{2+}}$, $\\mathrm{Ni^{2+}}$, and $\\mathrm{Ca^{2+}}$ compete for this site. Let $S_{\\mathrm{Mg}}$, $S_{\\mathrm{Ni}}$, and $S_{\\mathrm{Ca}}$ represent the site bound by each respective cation.\n\nAccording to the principle of conservation of mass for the binding site, the total concentration of sites is the sum of the concentrations of the free and bound forms:\n$$[S]_{tot} = [S] + [S_{\\mathrm{Mg}}] + [S_{\\mathrm{Ni}}] + [S_{\\mathrm{Ca}}]$$\n\nThe binding of each cation $M$ (where $M$ is $\\mathrm{Mg^{2+}}$, $\\mathrm{Ni^{2+}}$, or $\\mathrm{Ca^{2+}}$) is described by a dissociation equilibrium:\n$$S_M \\rightleftharpoons S + M$$\nThe law of mass action applied to these equilibria gives the dissociation constants, $K_d$:\n$$K_{d,\\mathrm{Mg}} = \\frac{[S][\\mathrm{Mg^{2+}}]}{[S_{\\mathrm{Mg}}]}$$\n$$K_{d,\\mathrm{Ni}} = \\frac{[S][\\mathrm{Ni^{2+}}]}{[S_{\\mathrm{Ni}}]}$$\n$$K_{d,\\mathrm{Ca}} = \\frac{[S][\\mathrm{Ca^{2+}}]}{[S_{\\mathrm{Ca}}]}$$\n\nFrom these definitions, we can express the concentration of each bound state in terms of the free site concentration, $[S]$, and the free cation concentrations:\n$$[S_{\\mathrm{Mg}}] = \\frac{[S][\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}}$$\n$$[S_{\\mathrm{Ni}}] = \\frac{[S][\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}}$$\n$$[S_{\\mathrm{Ca}}] = \\frac{[S][\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}}$$\n\nSubstituting these expressions into the site conservation equation allows us to relate $[S]_{tot}$ to $[S]$:\n$$[S]_{tot} = [S] + \\frac{[S][\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[S][\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[S][\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}}$$\nFactoring out $[S]$ yields:\n$$[S]_{tot} = [S] \\left( 1 + \\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}} \\right)$$\n\nThe problem states that the initial rate, $v$, is proportional to the effective amount of catalytically competent complexes. The $\\mathrm{Mg^{2+}}$-bound complex is fully functional (efficacy $1$), the $\\mathrm{Ni^{2+}}$-bound complex is partially functional (efficacy $\\alpha$), and the $\\mathrm{Ca^{2+}}$-bound complex is inactive (efficacy $0$). The total effective concentration of active complexes is therefore $[S_{\\mathrm{Mg}}] + \\alpha[S_{\\mathrm{Ni}}]$.\nThus, the rate $v$ is given by:\n$$v = C \\cdot ([S_{\\mathrm{Mg}}] + \\alpha[S_{\\mathrm{Ni}}])$$\nwhere $C$ is a proportionality constant. Since the total concentration of sites $[S]_{tot}$ is constant for the experiment, it is convenient to work with fractional occupancies. Let $\\theta_M = [S_M]/[S]_{tot}$ be the fraction of total sites occupied by cation $M$. The rate is proportional to the effective fractional occupancy, $\\Phi_{eff}$:\n$$v \\propto \\Phi_{eff} = \\theta_{\\mathrm{Mg}} + \\alpha \\theta_{\\mathrm{Ni}}$$\nTo find an explicit expression for $\\Phi_{eff}$, we first derive the expression for the fractional occupancy of each species. For example, for $\\mathrm{Mg^{2+}}$:\n$$\\theta_{\\mathrm{Mg}} = \\frac{[S_{\\mathrm{Mg}}]}{[S]_{tot}} = \\frac{\\frac{[S][\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}}}{[S] \\left( 1 + \\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}} \\right)} = \\frac{\\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}}}{1 + \\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}}}$$\nSimilarly for $\\mathrm{Ni^{2+}}$:\n$$\\theta_{\\mathrm{Ni}} = \\frac{\\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}}}{1 + \\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}}}$$\nThe effective fractional occupancy is then:\n$$\\Phi_{eff} = \\theta_{\\mathrm{Mg}} + \\alpha \\theta_{\\mathrm{Ni}} = \\frac{\\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\alpha \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}}}{1 + \\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}}}$$\nThe ratio of the rates in Buffer B versus Buffer A is simply the ratio of their respective effective fractional occupancies, as the proportionality constant cancels:\n$$\\frac{v_B}{v_A} = \\frac{\\Phi_{eff, B}}{\\Phi_{eff, A}}$$\n\nTo simplify calculations, we define the dimensionless normalized concentration for each cation $M$ as $\\chi_M = [M]/K_{d,M}$.\nThe expression for $\\Phi_{eff}$ becomes:\n$$\\Phi_{eff} = \\frac{\\chi_{\\mathrm{Mg}} + \\alpha \\chi_{\\mathrm{Ni}}}{1 + \\chi_{\\mathrm{Mg}} + \\chi_{\\mathrm{Ni}} + \\chi_{\\mathrm{Ca}}}$$\n\nThe provided data are:\n$K_{d,\\mathrm{Mg}} = 0.20\\,\\mathrm{mM}$, $K_{d,\\mathrm{Ni}} = 0.050\\,\\mathrm{mM}$, $K_{d,\\mathrm{Ca}} = 2.0\\,\\mathrm{mM}$, and $\\alpha = 0.35$.\n\nFor Buffer A:\n$[\\mathrm{Mg^{2+}}]_{A} = 0.6\\,\\mathrm{mM}$, $[\\mathrm{Ni^{2+}}]_{A} = 0\\,\\mathrm{mM}$, $[\\mathrm{Ca^{2+}}]_{A} = 1.2\\,\\mathrm{mM}$.\nThe normalized concentrations are:\n$$\\chi_{\\mathrm{Mg},A} = \\frac{0.6}{0.20} = 3.0$$\n$$\\chi_{\\mathrm{Ni},A} = \\frac{0}{0.050} = 0$$\n$$\\chi_{\\mathrm{Ca},A} = \\frac{1.2}{2.0} = 0.6$$\nThe effective fractional occupancy for Buffer A is:\n$$\\Phi_{eff, A} = \\frac{3.0 + (0.35)(0)}{1 + 3.0 + 0 + 0.6} = \\frac{3.0}{4.6}$$\n\nFor Buffer B:\n$[\\mathrm{Mg^{2+}}]_{B} = 1.0\\,\\mathrm{mM}$, $[\\mathrm{Ni^{2+}}]_{B} = 0.020\\,\\mathrm{mM}$, $[\\mathrm{Ca^{2+}}]_{B} = 0.001\\,\\mathrm{mM}$.\nThe normalized concentrations are:\n$$\\chi_{\\mathrm{Mg},B} = \\frac{1.0}{0.20} = 5.0$$\n$$\\chi_{\\mathrm{Ni},B} = \\frac{0.020}{0.050} = 0.4$$\n$$\\chi_{\\mathrm{Ca},B} = \\frac{0.001}{2.0} = 0.0005$$\nThe effective fractional occupancy for Buffer B is:\n$$\\Phi_{eff, B} = \\frac{5.0 + (0.35)(0.4)}{1 + 5.0 + 0.4 + 0.0005} = \\frac{5.0 + 0.14}{6.4005} = \\frac{5.14}{6.4005}$$\n\nFinally, we compute the fold-change in the initial rate:\n$$\\frac{v_B}{v_A} = \\frac{\\Phi_{eff, B}}{\\Phi_{eff, A}} = \\frac{5.14 / 6.4005}{3.0 / 4.6} = \\frac{5.14 \\times 4.6}{3.0 \\times 6.4005} = \\frac{23.644}{19.2015} \\approx 1.231364...$$\n\nRounding the result to four significant figures as requested yields $1.231$.", "answer": "$$\\boxed{1.231}$$", "id": "2896988"}, {"introduction": "While powerful, the alternative pathway's amplification loop must be tightly controlled to prevent it from damaging host tissues. This protective function is largely mediated by Factor H, which specifically recognizes host cell surfaces and inactivates any C3b deposited there. In this quantitative practice [@problem_id:2273464], you will analyze a simplified kinetic model to calculate the dramatic consequence of a Factor H mutation that abolishes its ability to concentrate on host cells, thereby quantifying the critical importance of spatial localization in immune self-tolerance.", "problem": "The alternative pathway of the complement system provides a rapid defense mechanism against pathogens but must be tightly regulated to prevent damage to host cells. A key regulator is Complement factor H (Factor H), which binds to polyanionic molecules like sialic acid on host cell surfaces via its C-terminal domain, and uses its N-terminal domain to inactivate nearby C3b molecules. This prevents the explosive amplification of C3b deposition on host tissues.\n\nConsider a simplified kinetic model for the deposition of C3b on a host cell surface. The steady-state surface concentration of C3b, denoted $[C3b]_{ss}$, is determined by a balance between its formation and its inactivation. The relationship is given by:\n\n$$ [C3b]_{ss} = \\frac{R_{tick}}{k_{inact, H} [H]_{local} - k_{net\\_amp}} $$\n\nwhere:\n- $R_{tick}$ is the constant rate of initial C3b deposition due to spontaneous C3 hydrolysis.\n- $[H]_{local}$ is the local concentration of functional Factor H at the cell surface.\n- $k_{inact, H}$ is the rate constant for C3b inactivation, which requires Factor H as a cofactor for the enzyme Factor I. Its value is $1.20 \\times 10^{5} \\text{ M}^{-1}\\text{s}^{-1}$.\n- $k_{net\\_amp}$ is the net amplification rate constant, representing the autocatalytic C3 convertase activity minus intrinsic decay. Its value is $0.300 \\text{ s}^{-1}$. A positive value indicates that the amplification loop is inherently unstable and requires active regulation from Factor H.\n\nIn a healthy individual with wild-type (WT) Factor H, the plasma concentration is $[H]_{plasma} = 3.00 \\times 10^{-6} \\text{ M}$. The C-terminal binding to the host cell surface concentrates the protein, making its effective local concentration at the surface, $[H]_{local, WT}$, equal to 50.0 times its plasma concentration.\n\nNow, consider a patient with a rare genetic mutation. This mutation selectively ablates the C-terminal host-recognition domain of Factor H, but leaves the N-terminal regulatory domain and its plasma concentration unchanged. For this mutant (MUT) Factor H, the protein can no longer be concentrated at the host cell surface, so its local concentration is simply its plasma concentration, i.e., $[H]_{local, MUT} = [H]_{plasma}$.\n\nCalculate the ratio of the steady-state C3b concentration on a host cell in the patient with the mutant Factor H to that in a healthy individual, i.e., $\\frac{[C3b]_{ss, MUT}}{[C3b]_{ss, WT}}$. Round your final answer to three significant figures.", "solution": "We are given the steady-state relation\n$$[C3b]_{ss}=\\frac{R_{tick}}{k_{inact,H}[H]_{local}-k_{net\\_amp}}.$$\nFor wild type (WT) and mutant (MUT), the ratio is\n$$\\frac{[C3b]_{ss,MUT}}{[C3b]_{ss,WT}}=\\frac{k_{inact,H}[H]_{local,WT}-k_{net\\_amp}}{k_{inact,H}[H]_{local,MUT}-k_{net\\_amp}},$$\nsince $R_{tick}$ cancels.\n\nThe local concentrations are\n$$[H]_{local,WT}=50.0\\,[H]_{plasma},\\qquad [H]_{local,MUT}=[H]_{plasma}.$$\nFirst compute $k_{inact,H}[H]_{plasma}$:\n$$k_{inact,H}[H]_{plasma}=\\left(1.20\\times 10^{5}\\right)\\left(3.00\\times 10^{-6}\\right)=3.60\\times 10^{-1}\\ \\text{s}^{-1}=0.360\\ \\text{s}^{-1}.$$\nThen\n$$k_{inact,H}[H]_{local,WT}=50.0\\times 0.360=18.0\\ \\text{s}^{-1},\\qquad k_{inact,H}[H]_{local,MUT}=0.360\\ \\text{s}^{-1}.$$\nSubtracting $k_{net\\_amp}=0.300\\ \\text{s}^{-1}$,\n$$\\text{denominator}_{WT}=18.0-0.300=17.7\\ \\text{s}^{-1},\\qquad \\text{denominator}_{MUT}=0.360-0.300=0.060\\ \\text{s}^{-1}.$$\nTherefore,\n$$\\frac{[C3b]_{ss,MUT}}{[C3b]_{ss,WT}}=\\frac{17.7}{0.060}=295.$$\nRounded to three significant figures, this is $2.95\\times 10^{2}$.", "answer": "$$\\boxed{2.95\\times 10^{2}}$$", "id": "2273464"}, {"introduction": "The power of the alternative pathway lies in its explosive amplification loop, which is strongly influenced by the stability of the C3 convertase. While the convertase has a short intrinsic half-life, the positive regulator properdin can bind and extend its functional lifetime dramatically. This problem [@problem_id:2896993] guides you through a kinetic analysis of the convertase's life cycle, modeling it as a two-state system to determine its expected lifetime and, consequently, its total catalytic output. This will provide a quantitative measure of properdin's role as a critical amplifier of the complement response.", "problem": "A central amplification step in the alternative pathway of complement is the formation of the C3 convertase complex C3bBb, which cleaves C3 into C3a and C3b. Properdin (Factor P) binds and stabilizes C3bBb, prolonging its functional lifetime. Assume the following mechanistic base:\n\n- The active convertase exists in two interconverting states on the surface: an unstabilized state, denoted by $U$ (C3bBb), and a properdin-stabilized state, denoted by $S$ (C3bBbP). \n- Properdin binding to $U$ occurs with a second-order association rate constant $k_{\\text{on}}$ and a free properdin concentration $[P]$, giving a first-order binding rate $a = k_{\\text{on}}[P]$ (transition $U \\to S$). Properdin dissociation from $S$ occurs with a first-order rate constant $k_{\\text{off}}$ (transition $S \\to U$).\n- Inactivation (disassembly) of the convertase from $U$ and $S$ are independent, memoryless events with first-order rate constants $b$ and $d$, respectively. The corresponding half-lives are $t_{1/2,U}$ and $t_{1/2,S}$, such that $b = (\\ln 2)/t_{1/2,U}$ and $d = (\\ln 2)/t_{1/2,S}$.\n- While active (in either state $U$ or $S$), each convertase cleaves C3 at a constant catalytic turnover rate $k_{\\text{cat}}$; properdin binding does not change $k_{\\text{cat}}$.\n- Each convertase formation consumes one molecule of Factor B stoichiometrically. Define the efficiency as the expected number of C3 molecules cleaved per molecule of Factor B consumed; this equals the expected total number of C3 turnovers accomplished by a single convertase over its lifetime.\n\nStarting from these foundations, model the convertase lifetime as a continuous-time, two-state Markov process with absorption by inactivation. Derive, from first principles, the expected lifetime starting in $U$ at time $t=0$, and then compute the efficiency as $k_{\\text{cat}}$ times this expected lifetime, using the following experimentally plausible parameters:\n\n- Unstabilized convertase half-life $t_{1/2,U} = 90\\ \\mathrm{s}$.\n- Properdin-stabilized convertase half-life $t_{1/2,S} = 900\\ \\mathrm{s}$.\n- Properdin association rate constant $k_{\\text{on}} = 2.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$.\n- Properdin dissociation rate constant $k_{\\text{off}} = 2.0 \\times 10^{-2}\\ \\mathrm{s}^{-1}$.\n- Free properdin concentration $[P] = 50\\ \\mathrm{nM}$.\n- Convertase catalytic turnover $k_{\\text{cat}} = 15\\ \\mathrm{s}^{-1}$.\n\nExpress your final answer as the number of C3 molecules cleaved per Factor B consumed. Round your answer to three significant figures.", "solution": "The problem statement is scientifically grounded, well-posed, objective, and provides a complete and consistent set of parameters to model the lifetime of a C3 convertase. It is a valid problem in quantitative biology.\n\nThe system is modeled as a continuous-time Markov process with two transient states, $U$ (unstabilized) and $S$ (stabilized), and an absorbing state representing inactivation. The process begins in state $U$ at time $t=0$. The transitions are governed by first-order rate constants:\n- $U \\to S$: rate $a = k_{\\text{on}}[P]$\n- $S \\to U$: rate $k_{\\text{off}}$\n- $U \\to \\text{inactivated}$: rate $b$\n- $S \\to \\text{inactivated}$: rate $d$\n\nLet $P_U(t)$ and $P_S(t)$ be the probabilities that the convertase is in state $U$ or $S$ at time $t$, respectively, given it started in state $U$ at $t=0$. The time evolution of these probabilities is described by the following system of coupled linear ordinary differential equations:\n$$\n\\frac{dP_U(t)}{dt} = - (a+b)P_U(t) + k_{\\text{off}}P_S(t)\n$$\n$$\n\\frac{dP_S(t)}{dt} = aP_U(t) - (k_{\\text{off}}+d)P_S(t)\n$$\nThe initial conditions are $P_U(0)=1$ and $P_S(0)=0$, as the convertase is formed in the unstabilized state.\n\nThe expected lifetime of the convertase, starting from state $U$, which we denote as $E_U$, is the total time the system spends in any active state ($U$ or $S$) before inactivation. This can be calculated by integrating the total survival probability, $P_U(t) + P_S(t)$, from $t=0$ to $t=\\infty$:\n$$\nE_U = \\int_0^\\infty \\left( P_U(t) + P_S(t) \\right) dt\n$$\nThis can be expressed as the sum of the total time spent in state $U$, let's call it $T_U = \\int_0^\\infty P_U(t) dt$, and the total time spent in state $S$, $T_S = \\int_0^\\infty P_S(t) dt$.\n\nWe can find $T_U$ and $T_S$ by integrating the system of differential equations over the entire time course from $t=0$ to $t=\\infty$. For any state $i$, $\\int_0^\\infty \\frac{dP_i(t)}{dt} dt = P_i(\\infty) - P_i(0)$. Since inactivation is an absorbing state, $P_U(\\infty) = 0$ and $P_S(\\infty) = 0$.\n\nIntegrating the first equation:\n$$\n\\int_0^\\infty \\frac{dP_U(t)}{dt} dt = P_U(\\infty) - P_U(0) = 0 - 1 = -1\n$$\n$$\n-1 = - (a+b) \\int_0^\\infty P_U(t) dt + k_{\\text{off}} \\int_0^\\infty P_S(t) dt\n$$\n$$\n-1 = - (a+b)T_U + k_{\\text{off}}T_S\n$$\n\nIntegrating the second equation:\n$$\n\\int_0^\\infty \\frac{dP_S(t)}{dt} dt = P_S(\\infty) - P_S(0) = 0 - 0 = 0\n$$\n$$\n0 = a \\int_0^\\infty P_U(t) dt - (k_{\\text{off}}+d) \\int_0^\\infty P_S(t) dt\n$$\n$$\n0 = aT_U - (k_{\\text{off}}+d)T_S\n$$\n\nWe now have a system of two linear equations for $T_U$ and $T_S$:\n1. $(a+b)T_U - k_{\\text{off}}T_S = 1$\n2. $aT_U - (k_{\\text{off}}+d)T_S = 0$\n\nFrom equation (2), we express $T_S$ in terms of $T_U$:\n$$\nT_S = \\frac{a}{k_{\\text{off}}+d}T_U\n$$\nSubstitute this into equation (1):\n$$\n(a+b)T_U - k_{\\text{off}}\\left(\\frac{a}{k_{\\text{off}}+d}T_U\\right) = 1\n$$\n$$\nT_U \\left( (a+b) - \\frac{ak_{\\text{off}}}{k_{\\text{off}}+d} \\right) = 1\n$$\n$$\nT_U \\left( \\frac{(a+b)(k_{\\text{off}}+d) - ak_{\\text{off}}}{k_{\\text{off}}+d} \\right) = 1\n$$\n$$\nT_U \\left( \\frac{ak_{\\text{off}} + ad + bk_{\\text{off}} + bd - ak_{\\text{off}}}{k_{\\text{off}}+d} \\right) = 1\n$$\n$$\nT_U \\left( \\frac{ad + bk_{\\text{off}} + bd}{k_{\\text{off}}+d} \\right) = 1\n$$\nSolving for $T_U$:\n$$\nT_U = \\frac{k_{\\text{off}}+d}{ad + bk_{\\text{off}} + bd}\n$$\nNow we find $T_S$:\n$$\nT_S = \\frac{a}{k_{\\text{off}}+d} \\left( \\frac{k_{\\text{off}}+d}{ad + bk_{\\text{off}} + bd} \\right) = \\frac{a}{ad + bk_{\\text{off}} + bd}\n$$\nThe total expected lifetime $E_U$ is the sum of $T_U$ and $T_S$:\n$$\nE_U = T_U + T_S = \\frac{k_{\\text{off}}+d}{ad + bk_{\\text{off}} + bd} + \\frac{a}{ad + bk_{\\text{off}} + bd} = \\frac{a + k_{\\text{off}} + d}{ad + b k_{\\text{off}} + bd}\n$$\nThis is the symbolic expression for the expected lifetime starting from state $U$.\n\nNext, we calculate the numerical values of the rate constants using the given parameters:\n- $a = k_{\\text{on}}[P] = (2.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}) \\times (50 \\times 10^{-9}\\ \\mathrm{M}) = 0.1\\ \\mathrm{s}^{-1}$\n- $b = \\frac{\\ln 2}{t_{1/2,U}} = \\frac{\\ln 2}{90}\\ \\mathrm{s}^{-1}$\n- $d = \\frac{\\ln 2}{t_{1/2,S}} = \\frac{\\ln 2}{900}\\ \\mathrm{s}^{-1}$\n- $k_{\\text{off}} = 2.0 \\times 10^{-2}\\ \\mathrm{s}^{-1} = 0.02\\ \\mathrm{s}^{-1}$\n\nLet's compute the numerator and denominator of the expression for $E_U$:\nNumerator:\n$$\na + k_{\\text{off}} + d = 0.1 + 0.02 + \\frac{\\ln 2}{900} = 0.12 + \\frac{\\ln 2}{900}\\ \\mathrm{s}^{-1}\n$$\nDenominator:\n$$\nad + b k_{\\text{off}} + bd = (0.1)\\left(\\frac{\\ln 2}{900}\\right) + \\left(\\frac{\\ln 2}{90}\\right)(0.02) + \\left(\\frac{\\ln 2}{90}\\right)\\left(\\frac{\\ln 2}{900}\\right)\n$$\nWe can factor out $\\frac{\\ln 2}{900}$:\n$$\n\\text{Denominator} = \\frac{\\ln 2}{900} \\left( 0.1 + 10 \\times 0.02 + \\frac{\\ln 2}{90} \\right) = \\frac{\\ln 2}{900} \\left( 0.1 + 0.2 + \\frac{\\ln 2}{90} \\right) = \\frac{\\ln 2}{900} \\left( 0.3 + \\frac{\\ln 2}{90} \\right)\\ \\mathrm{s}^{-2}\n$$\nUsing $\\ln 2 \\approx 0.693147$:\n$b = \\frac{0.693147}{90} \\approx 0.0077016\\ \\mathrm{s}^{-1}$\n$d = \\frac{0.693147}{900} \\approx 0.00077016\\ \\mathrm{s}^{-1}$\nNumerator $\\approx 0.12 + 0.00077016 = 0.12077016\\ \\mathrm{s}^{-1}$\nDenominator $\\approx (0.1)(0.00077016) + (0.0077016)(0.02) + (0.0077016)(0.00077016)$\nDenominator $\\approx 0.000077016 + 0.000154032 + 0.0000059315 = 0.0002369795\\ \\mathrm{s}^{-2}$\n\n$$\nE_U \\approx \\frac{0.12077016}{0.0002369795} \\approx 509.613\\ \\mathrm{s}\n$$\nThe problem defines efficiency as the expected total number of C3 molecules cleaved, which is the product of the catalytic rate $k_{\\text{cat}}$ and the expected lifetime $E_U$.\n$$\n\\text{Efficiency} = k_{\\text{cat}} \\times E_U\n$$\nGiven $k_{\\text{cat}} = 15\\ \\mathrm{s}^{-1}$:\n$$\n\\text{Efficiency} = 15\\ \\mathrm{s}^{-1} \\times 509.613\\ \\mathrm{s} \\approx 7644.195\n$$\nThe problem requires the answer to be rounded to three significant figures.\n$$\n\\text{Efficiency} \\approx 7640\n$$\nIn scientific notation, this is $7.64 \\times 10^3$.", "answer": "$$\\boxed{7.64 \\times 10^3}$$", "id": "2896993"}]}